Profile data is unavailable for this security.
About the company
Shandong Weigao Orthopaedic Device Co Ltd is a China-based company mainly engaged in the research and development, production and sales of orthopedic medical devices. The Company's products include orthopedic implanted medical devices and orthopedic surgical instruments. The Company's products cover various orthopedic implanted medical device fields such as spine, trauma, joint and sports medicine, among others. The Company mainly conducts its businesses within domestic market.
- Revenue in CNY (TTM)1.28bn
- Net income in CNY154.60m
- Incorporated2005
- Employees2.21k
- LocationShandong Weigao Orthopaedic Device Co LtdNo. 26 Xiangjiang Street, Tourist ResortWEIHAI 264209ChinaCHN
- Phone+86 6 315788909
- Fax+86 6 315660958
- Websitehttp://www.wegortho.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vcanbio Cell & Gene Engineering Corp Ltd | 1.59bn | 107.45m | 9.69bn | 2.21k | 87.94 | 2.68 | -- | 6.08 | 0.2354 | 0.2354 | 3.45 | 7.73 | 0.2977 | 1.90 | 2.59 | 721,260.30 | 1.90 | 1.13 | 2.68 | 1.61 | 68.10 | 67.76 | 6.38 | 3.84 | 1.48 | 7.89 | 0.0296 | 0.00 | 2.24 | 3.78 | -5.78 | 12.43 | -7.11 | -- |
| Shanghai Microport EP MedTech Co Ltd | 383.99m | 35.90m | 10.08bn | 577.00 | 280.68 | 5.82 | -- | 26.24 | 0.0763 | 0.0763 | 0.816 | 3.68 | 0.2081 | 1.30 | 7.04 | 665,493.30 | 1.95 | -- | 2.05 | -- | 57.86 | -- | 9.35 | -- | 13.82 | -- | 0.0109 | -- | 26.46 | -- | 85.17 | -- | -- | -- |
| Shenzhen YHLO Biotech Co Ltd | 1.90bn | 288.64m | 10.39bn | 1.76k | 36.25 | 3.91 | -- | 5.46 | 0.5026 | 0.5026 | 3.32 | 4.66 | 0.4842 | 1.07 | 4.58 | 1,081,307.00 | 5.85 | 16.43 | 7.46 | 24.16 | 63.98 | 53.26 | 12.08 | 20.01 | 1.28 | 9.13 | 0.2474 | 30.28 | -48.42 | 23.02 | -64.93 | 56.32 | 28.88 | -- |
| Qingdao Haier Biomedical Co Ltd | 2.24bn | 358.01m | 11.05bn | 2.64k | 30.83 | 2.57 | -- | 4.94 | 1.13 | 1.13 | 7.04 | 13.53 | 0.4018 | 5.12 | 6.38 | 848,473.70 | 6.56 | 11.49 | 8.29 | 15.22 | 47.82 | 49.98 | 16.34 | 25.20 | 2.53 | -- | 0.0316 | 26.53 | -20.36 | 22.07 | -32.41 | 28.94 | 20.64 | -- |
| Shinva Medical Instrument Co Ltd | 10.12bn | 692.34m | 11.11bn | 8.21k | 12.96 | 1.48 | -- | 1.10 | 1.41 | 1.41 | 18.31 | 12.34 | 0.6775 | 2.20 | 4.96 | 1,232,589.00 | 4.72 | 4.63 | 9.14 | 10.76 | 25.62 | 24.22 | 6.96 | 6.12 | 0.8303 | -- | 0.1637 | 15.91 | 7.87 | -0.5342 | 30.78 | 95.70 | -5.90 | 61.86 |
| Shandong Weigao Orthopaedic Devce Co Ltd | 1.28bn | 154.60m | 11.55bn | 2.21k | 74.83 | 2.95 | -- | 8.99 | 0.3858 | 0.3858 | 3.20 | 9.78 | 0.2524 | 0.6714 | 4.03 | 581,131.60 | 3.14 | 10.97 | 3.95 | 13.69 | 62.40 | 77.33 | 12.43 | 27.08 | 3.62 | -- | 0.0096 | 17.90 | -30.55 | 1.17 | -79.36 | -19.11 | -4.31 | -- |
| Shanghai Runda Medical Technology Co Ltd | 8.43bn | 40.27m | 11.91bn | 3.32k | 295.31 | 2.77 | -- | 1.41 | 0.0673 | 0.0673 | 13.61 | 7.17 | 0.5831 | 4.19 | 1.49 | 2,543,990.00 | 1.18 | 4.78 | 3.13 | 12.86 | 25.94 | 27.13 | 2.03 | 6.36 | 1.01 | 3.04 | 0.5609 | 12.43 | -12.84 | 8.93 | -34.58 | 0.8514 | 3.88 | 1.03 |
| Beijing Wandong Medical Technolgy Co Ltd | 1.40bn | 184.09m | 12.30bn | 1.06k | 66.79 | 2.60 | -- | 8.76 | 0.262 | 0.262 | 2.00 | 6.74 | 0.2647 | 2.76 | 4.01 | 1,325,746.00 | 3.50 | 5.30 | 3.91 | 6.21 | 38.83 | 45.21 | 13.22 | 16.46 | 9.48 | -- | 0.0179 | 35.82 | 10.30 | 5.32 | 7.51 | 4.22 | -16.66 | 5.39 |
| Shanghai MicroPort Edvcl MdTch Grp CoLtd | 1.27bn | 657.34m | 13.31bn | 908.00 | 19.85 | 3.42 | -- | 10.50 | 5.44 | 5.44 | 10.59 | 31.54 | 0.371 | 1.33 | 6.51 | 1,396,816.00 | 19.00 | 17.68 | 21.55 | 19.43 | 74.51 | 76.60 | 51.21 | 42.25 | 5.49 | -- | 0.0067 | 44.46 | 32.43 | 38.72 | 37.98 | 40.28 | 50.18 | -- |
| Sansure Biotech Inc | 1.41bn | 259.42m | 13.73bn | 2.01k | 52.67 | 1.87 | -- | 9.76 | 0.4475 | 0.4475 | 2.44 | 12.62 | 0.1667 | 0.878 | 2.03 | 701,473.70 | 2.52 | 26.74 | 2.79 | 30.97 | 76.43 | 67.47 | 15.12 | 42.01 | 7.45 | -- | 0.0583 | 22.40 | -84.39 | 27.12 | -81.22 | 121.89 | 64.08 | -- |
Data as of Nov 22 2024. Currency figures normalised to Shandong Weigao Orthopaedic Device Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
1.57%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research (Hong Kong) Ltd.as of 30 Sep 2024 | 1.96m | 0.49% |
| Fidelity Management & Research Co. LLCas of 30 Sep 2024 | 1.32m | 0.33% |
| Eastspring Investments (Singapore) Ltd.as of 30 Aug 2024 | 540.44k | 0.14% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 495.56k | 0.12% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2024 | 472.51k | 0.12% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 435.42k | 0.11% |
| Tebon Fund Management Co. Ltd.as of 30 Jun 2024 | 420.27k | 0.11% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 238.28k | 0.06% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 222.69k | 0.06% |
| HuaAn Fund Management Co., Ltd.as of 30 Jun 2024 | 189.95k | 0.05% |
More ▼
Data from 30 Jun 2024 - 11 Nov 2024Source: FactSet Research Systems Inc.
